However, it's hard to assume all GLP-1 drugs will work the same way for migraine, according to Jodi Nagelberg, MD, an endocrinologist and assistant professor of medicine at the University of California, San Diego
Highlights Type 2 diabetes mellitus (T2DM) is currently a global epidemic, affecting 537 million individuals worldwide
Klinic's proactive management verifies everything before care begins
Cognition Animal studies suggested the GLP-1 RAs may improve cognition, but results in humans have been inconclusive
The trial met its primary endpoint, showing a biopsy-proven improvement in MASH after 48 weeks, without worsening of fibrosis stages F1, F2 and F3 (mild to moderate or advanced scarring)